Authors


William F. Gee, MD

Latest:

Urologists are well positioned for 2010

In spite of the chaos of health care reform, urologists' mix of office, outpatient surgery, and hospital practice ensures that we will continue to do well.


John J. Mulcahy, MD, PhD

Latest:

ED after PCa therapy: Still problematic, but treatable

Patients should be advised that ED is a good possibility with any form of treatment.


Ray Painter, MD

Latest:

Urologists should avoid unbundling instillation, in/out catheter

Make sure that you are coding correctly for the instillation based on the type of drug you are using and charge separately for the drugs that are instilled.


Arieh Shalhav, MD

Latest:

Managing laparoscopic injuries: An addendum

This addendum includes advice on managing gas emboli/vascular insufflation,vascular injuries, subcutaneous emphysema, pneumomediastinum, and pneumothoraxArieh L. Shalhav, MD, is associate professor of surgery and directorof minimally invasive urology, and Marcelo A. Orvieto, MD, is a fellowin minimally invasive urology, University of Chicago.As discussed in a recent "Hands On" article ("How to preventand manage laparoscopic injuries," July 2003, page 50), the overallcomplication rate related to urologic laparoscopy is approximately 4%, varyingwidely according to the procedure's technical difficulty. In this addendumto the article, we discuss how urologists can prevent and manage additionalcomplications associated with laparoscopy, including gas emboli/vascularinsufflation, vascular injuries, subcutaneous emphysema, pneumomediastinum,and pneumothorax.


J. Curtis Nickel, MD

Latest:

Managing chronic prostatitis: A modern approach

Nearly one in 10 men who walk into the outpatient office of a urologist leave with a coded diagnosis of prostatitis. Urologists have described the traditional approach to the diagnosis and management of the chronic prostatitis syndromes as one of the most frustrating areas of urologic practice.


Willet F. Whitmore, III, MD

Latest:

How to perform transperineal saturation prostate biopsy

The inherent limitations of the standard transrectal ultrasound approach for prostate biopsy have led to both diagnostic and therapeutic dilemmas.


Winston E. Barzell, MD

Latest:

How to perform transperineal saturation prostate biopsy

The inherent limitations of the standard transrectal ultrasound approach for prostate biopsy have led to both diagnostic and therapeutic dilemmas.


Emma Hitt, PhD

Latest:

Neoadjuvant chemo is well tolerated in high-risk PCa

Atlanta-Neoadjuvant docetaxel added to androgen suppression therapy and radiation therapy appears to be safe and active in patients with high-risk localized prostate cancer, according to findings of a new phase II study from Canada reported here at the American Society of Clinical Oncology annual meeting.


Craig S. Niederberger, MD

Latest:

Infertility story offers a lesson for all urologists

This story about the operating microscope and the vas has two morals.


Schlomo Raz, MD

Latest:

Evidence-based medicine drives new approach to SUI

The lifetime risk of undergoing surgery for incontinence or vaginal prolapsein the United States is nearly one in 11. As our population ages and lifeexpectancies increase, a greater number of women will present with pelvicfloor and voiding disorders. Because of this, there is significant interestin using evidence-based research to assess current diagnostic tools in theevaluation of stress urinary incontinence (SUI), as well as new potentialtreatments.


Nancy B. Itano, MD

Latest:

Evidence-based medicine drives new approach to SUI

The lifetime risk of undergoing surgery for incontinence or vaginal prolapsein the United States is nearly one in 11. As our population ages and lifeexpectancies increase, a greater number of women will present with pelvicfloor and voiding disorders. Because of this, there is significant interestin using evidence-based research to assess current diagnostic tools in theevaluation of stress urinary incontinence (SUI), as well as new potentialtreatments.


Richard D. Williams, MD

Latest:

NFL, other partners help drive American Urological Association Foundation initiative

Sandra Vassos, MPH, executive director of the AUAF, discusses the foundation's increasingly visible initiatives.


Gerald L. Andriole, MD

Latest:

Unmet Needs and Future Directions in Risk Assessment For Prostate Cancer

Dr Andriole shares remaining unmet needs in prostate cancer risk assessment and shares his hopes for the future.


Lisette Hilton

Latest:

Treatment intensification in advanced prostate cancer: Real-world practice lags behind data

"It gives me a very rewarding experience…. I see patients with low-grade prostate cancer and when they become advanced prostate cancer, I already have a good relationship with them and don’t have to send them somewhere else," says Abhinav Sidana, MD, MPH.


Lisette Hilton

Latest:

Test could help detect bladder cancer recurrence

An easy-to-administer urine test looking for telomerase reverse transcriptase mutations helps detect recurring urothelial bladder cancer, especially non-muscle-invasive bladder cancer, early on, according to a new study.


Subbarao V. Yalla, MD

Latest:

How to use urodynamics to assess voiding dysfunction

Urodynamic tests should be tailored to an individual patient's suspected dysfunction


D. Duane Baldwin, MD

Latest:

Ureteroscopy: Surgeons show techniques, tips in videos

In these videos, high-volume stone surgeons demonstrate novel approaches to classification, visualization, and treatment of stones.


Philip M. Hanno, MD, MPH

Latest:

Subspecialization trends: Who’s doing what and where?

In this interview, Michael Palese, MD, discusses subspecialization, its benefits for clinicians and patients, and what the future “office urologist” may look like.


John Jesitus

Latest:

Robotic urologic surgery shows benefits for both physician, patient

While cost remains a concern, incorporating robotics into urologic laparoscopy appears to improve the experience for patients and physicians alike.


Lisette Hilton

Latest:

Beta-3 agonist significantly reduces urge incontinence

The oral beta-3 agonist vibegron, taken once daily at either 50 mg or 100 mg, is well tolerated and results in clinically and statistically significant reductions in daily micturitions, urge incontinence, and urgency episodes.


Colleen M. Padia

Latest:

Despite data, cautery-free RAP approach preferred

Cleveland-Although their data show otherwise, a group of researchers at the University of Rochester (NY) Medical Center have faith that using a cautery-free approach with Weck clips to preserve the neurovascular bundle during robot-assisted prostatectomy is a better choice than bipolar cautery.


Randy Dotinga

Latest:

Metallic stents efficacious for malignant ureteral obstruction

A new study suggests that metallic Resonance ureteral stents are a good option for management of malignant ureteral obstruction because they promote strong long-term outcomes.


Robert A. Dowling, MD

Latest:

How information blocking updates may affect your practice

"Urologists may wish to review their policies for patient portal, responding to requests for records, and supporting the concept of a shared electronic record," writes Robert A. Dowling, MD.


Kyle Richards MD.

Latest:

Treatment of metastatic renal cell carcinoma: What can we offer?

To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.


Scott Eggener MD.

Latest:

Treatment of metastatic renal cell carcinoma: What can we offer?

To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.


Bradley A. Erickson, MD, MS

Latest:

No business as usual post COVID? Maybe a good thing

"Professionally, I am mentally and logistically preparing for a different medical environment when we all return from isolation. I doubt it will ever be business as usual again," writes Bradley A. Erickson, MD, MS.


Henry Rosevear, MD

Latest:

Stones, stents, sepsis, and the need for some common sense

"If we can’t get the emergency rooms physicians to apply a bit of common sense to medicine, maybe we should require that they all have a ureteral stent placed for a few weeks during their residency so that they have a better idea of what these patients go through," writes Henry Rosevear, MD.


Deepak A. Kapoor, MD

Latest:

Letter: IMRT ownership study methodology unsound

"Utilization analysis of health care resources must be free of bias, methodologically sound, and relevant to current practice," writes Deepak A. Kapoor, MD.


Juan C. Calle, MD

Latest:

How to prevent stone formation in patients with metabolic syndrome

This article examines the relationship between the metabolic syndrome and kidney stone disease. We explain elements of the metabolic workup and practical strategies for prevention and management of stones in patients with the metabolic syndrome.


Don Schrader

Latest:

Best of AUA 2015: PCa surveillance, surgical controversies create buzz

Urology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas-an information-packed, condensed summary of the top papers and presentations.

© 2024 MJH Life Sciences

All rights reserved.